Lactose (India) Limited

LACTOSE6

INE058I01013

Food Processing

Market Closed - Bombay S.E. Other stock markets 11:00:56 01/07/2024 BST			5-day change	1st Jan Change
182 ^INR	+4.99%		-1.01%	+45.02%

02-14	Lactose Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
2023	Lactose Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	CI

Lactose India Limited Reports Earnings Results for the First Quarter Ended June 30, 2021

August 12, 2021 at 12:48 pm

Lactose India Limited announced earnings results for the first quarter ended June 30, 2021. For the first quarter, the company announced total revenue was INR 86.567 million compared to INR 64.251 million a year ago. Net loss was INR 6.535 million compared to INR 13.604 million a year ago. Basic loss per share from continuing operations was INR 0.57 compared to INR 1.34 a year ago.

Latest news about Lactose (India) Limited

Lactose Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-14	CI
Lactose Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-02	CI
Lactose Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/08/23	CI
Lactose Limited Reports Earnings Results for the Full Year Ended March 31, 2023	30/05/23	CI
Lactose Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	30/05/23	CI
Lactose Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14/02/23	CI
Lactose Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	14/11/22	CI
Lactose Limited Announces Change in Registered Office Address	09/08/22	CI
Lactose Limited Approves Re-Appointment of M/S. Cas & Co. as Statutory Auditors	17/06/22	CI
Lactose Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	17/05/22	CI
Lactose (India) Board to Consider Allotment of Equity Shares Upon Warrant Conversion	23/03/22	MT
Lactose Limited Appoints Dhaval Jayant Soni as Additional Director (Non-Executive Independent Director)	19/03/22	CI
Lactose Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	14/02/22	CI
Lactose Limited Announces the Resignation of Mahendrakumar Singhi Omprakash as Independent Director	30/12/21	CI
Lactose Limited Announces Resignation of Shyamsunder Toshniwal as Director	21/12/21	CI
Lactose Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	12/11/21	CI
Lactose India Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	12/08/21	CI
Lactose (India) : Swings to Profit in Fiscal Q4	06/07/21	MT
Lactose India Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	21/06/21	CI
Lactose India Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	11/02/21	CI
Lactose Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	10/11/20	CI
Lactose Limited announced that it has received INR 12.6 million in funding	01/11/20	CI
Lactose Limited announced that it expects to receive INR 12.6 million in funding	21/10/20	CI
Lactose India Limited Reports Earnings Results for the First Quarter Ended June 30, 2020	15/09/20	CI
Lactose India Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020	30/06/20	CI

Chart Lactose (India) Limited

Duration

Period

More charts

Company Profile

Lactose (India) Limited is an India-based pharmaceutical company engaged in the business of manufacturing, trading and carrying out job work and manufacturing of pharmaceutical products. The Company is principally engaged in the manufacturing of lactose monohydrate. The Company specializes in the manufacturing of excipients (lactose/liquid color coatings), lactulose, solid dosage forms and liquid dosage forms. It manufactures disaccharide lactulose. Lactulose is used in the treatment of constipation, hepatitis, encephalopathy, intestinal microflora, dental care, diabetes, chronic liver disease and as an effective prebiotic. It also manufactures dry granulated, film and lacquer coated tablets. The Company is also engaged in exporting uncoated and blister packed solid dose forms. The Company's plant is located at Taluka Savli, Vadodara, Gujarat. Its lactose manufacturing facility has a capacity of 10000 metric tons/annum with an average capacity of 30 metric tons/ day.

Sector

Food Processing

Calendar

12/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Food Processing

	1st Jan change	Capi.
LACTOSE (INDIA) LIMITED	+45.02%	26.18M
MONDELEZ INTERNATIONAL, INC.	-8.77%	87.78B
DANONE	-1.23%	39.37B
KRAFT HEINZ	-12.94%	39.12B
THE HERSHEY COMPANY	-1.74%	37.18B
GENERAL MILLS, INC.	-2.52%	35.31B
ARCHER-DANIELS-MIDLAND COMPANY	-15.87%	29.89B
NESTLÉ INDIA LIMITED	-3.46%	29.52B
ASSOCIATED BRITISH FOODS PLC	+5.13%	23.23B
YIHAI KERRY ARAWANA HOLDINGS CO., LTD	-17.17%	20.4B